Graduate of Food Engineering among the future 100 leaders in Biotechnology

Graduate of Food Engineering among the future 100 leaders in Biotechnology

Linda Guamán, a graduate of the Food Engineering career at the Universidad del Azuay, was chosen by GlobalBiotech Revolution as one of the 100 leaders of tomorrow in Biotechnology.

The institution, which is based at the Massachusetts Institute of Technology (MIT), seeks to connect current leaders in Biotechnology with those who will be tomorrow's new leaders in this discipline.

"I learned about the call because last year I was lucky enough to attend, as a scholarship holder, a synthetic biology event in San Francisco, and with this knowledge and through the web pages that I follow, I learned about the call to applications," he explained. Guaman

After the first filter, the graduate of the UDA was called for an interview, which she made through Skype, in which she answered questions related to her application and other questions of a personal nature to define her profile and suitability.

In the application, in addition to the curriculum vitae, the interested ones had to contribute ideas to relevant issues for GlobalBiotech Revolution as for example the reduction of the costs of medical products, the development of a sustainable agriculture and the protection of the population from the threat of bioterrorism.

"I chose the areas of biosecurity and sustainable agriculture because part of my doctorate, which I did at the University of Sao Paulo, involved working with agro-industrial waste," said Guaman.  

In addition to her doctorate, the Food Engineer completed a Master's degree in Microbiology at the University of Sao Paulo and is currently a researcher at the Equinoctial Technological University (UTE) in the use of Synthetic Biology and Metabolic Engineering tools.

The event, which will take place in June of this year, will put her in touch with current leaders in Biotechnology, such as the Chief Editor of Nature, the Dean of Medicine at Harvard University, a Nobel Prize in Medicine and CEO's of companies. pharmaceutical companies worldwide.

But first they will tell you which group they belong to because during the meeting the young entrepreneurs must present a biotechnological product that provides solutions to the relevant problems for the institution.

"The contest has an economic prize, which serves as a seed capital to address this venture," concluded the interviewee.